Company: COPL-UN
Filing Date: 2025-04-23
Form Type: S-1/A
Source: 0001829126-25-002866
Chunk: 275

Company: Copley Acquisition Corp
Filing Date: 2025-04-23
Form: S-1/A
Chunk 275
---
 offering, we will effect a share
capitalization or share surrender or repurchase or other appropriate mechanism, as applicable with respect to our Class B ordinary shares
immediately prior to the consummation of this offering in such amount as to maintain the ownership of founder shares by our sponsor at
25% of our issued and outstanding founder shares and public shares upon the consummation of this offering. Any additional Class B ordinary
shares issued to our sponsor through such a share capitalization would be issued at their nominal par value and may result in material
dilution to the implied value of the shares held by our public shareholders. Our sponsor does not intend to purchase any units in this
offering.

Our sponsor has committed
to purchase an aggregate of 499,643 placement units (555,893 placement units if the over-allotment option is exercised in full) for an
aggregate purchase price of $3,700,001 ($4,093,751 if the over-allotment option is exercised in full) in a private placement that will
occur simultaneously with the closing of this offering. Of the 499,643 placement units (or 555,893 placement units if the over-allotment
is exercised in full), the non-managing sponsor investors have expressed an interest to indirectly purchase, through the purchase of
non-managing sponsor membership interests, 67,500 of the placement units (whether or not the over-allotment option is exercised
in full) at a price of $10.00 per unit ($675,000 in the aggregate) in a private placement that will close simultaneously with the closing
of this offering. Subject to the non-managing sponsor investors purchasing, through the sponsor, the placement units allocated to them
in connection with the closing of this offering, the sponsor will issue membership interests at a nominal purchase price ($0.004) to
the non-managing sponsor investors reflecting their interest in an aggregate of 900,000 founder shares held by the sponsor (whether or
not the underwriters’ over-allotment option is exercised in full). The non-managing sponsor investors will have no right to
vote any securities that they hold indirectly through membership units of the sponsor or participate in any decision regarding the disposal
of any security held by the sponsor, or otherwise. There will be no redemption rights or liquidating distributions from the trust account
with respect to the founder shares, placement shares or placement warrants, which will expire worthless if we do not consummate a business